IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 94,078,963
- Share change
- -3,008,683
- Total reported value
- $2,559,895,530
- Put/Call ratio
- 20%
- Price per share
- $27.21
- Number of holders
- 221
- Value change
- -$71,222,974
- Number of buys
- 125
- Number of sells
- 88
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
13,137,294
|
$276,145,925 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.1%
from 13D/G
|
8,842,635
|
$185,872,188 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
7.3%
|
6,428,339
|
$174,915,104 | +$6,043,368 | 30 Sep 2025 | |
| Capital Research Global Investors |
13F
|
Company |
7.5%
|
6,552,691
|
$137,737,565 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
5.7%
|
5,028,279
|
$105,694,417 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.6%
|
4,941,945
|
$103,879,684 | — | 30 Jun 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
5.3%
|
4,627,266
|
$97,265,131 | — | 30 Jun 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
4.5%
|
3,915,311
|
$82,299,837 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
3,385,794
|
$71,169,390 | — | 30 Jun 2025 | |
| Logos Global Management LP |
13F
|
Company |
3.8%
|
3,345,000
|
$70,311,900 | — | 30 Jun 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
2.4%
|
2,147,795
|
$45,146,651 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.4%
|
2,118,728
|
$44,535,663 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,113,164
|
$44,424,149 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.2%
|
1,904,916
|
$40,043,000 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
1,825,903
|
$38,380,482 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.1%
|
1,805,136
|
$37,943,959 | — | 30 Jun 2025 | |
| Fiera Capital Corp |
13F
|
Company |
1.7%
|
1,532,269
|
$32,208,295 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
1,453,377
|
$30,549,990 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
1,238,094
|
$26,024,736 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
1,228,184
|
$25,816,428 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
923,705
|
$19,416,283 | — | 30 Jun 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1%
|
922,092
|
$19,382,372 | — | 30 Jun 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
1%
|
914,400
|
$19,221,507 | — | 30 Jun 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
771,844
|
$16,224,161 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.86%
|
751,905
|
$15,805,043 | — | 30 Jun 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.84%
|
741,833
|
$15,593,330 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.82%
|
716,798
|
$15,067,094 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
715,356
|
$15,036,783 | — | 30 Jun 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.7%
|
619,090
|
$13,013,272 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.6%
|
525,878
|
$11,053,956 | — | 30 Jun 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.58%
|
511,132
|
$10,743,994 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.51%
|
446,420
|
$9,383,748 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.5%
|
441,305
|
$9,276,231 | — | 30 Jun 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.49%
|
432,494
|
$9,091,024 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.47%
|
415,399
|
$8,731,687 | — | 30 Jun 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.46%
|
401,692
|
$8,443,566 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.43%
|
377,772
|
$7,941,000 | — | 30 Jun 2025 | |
| AXA S.A. |
13F
|
Company |
0.37%
|
324,543
|
$6,821,894 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.37%
|
321,166
|
$6,750,909 | — | 30 Jun 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
283,811
|
$5,965,707 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.31%
|
272,660
|
$5,731,313 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.3%
|
266,600
|
$5,603,932 | — | 30 Jun 2025 | |
| GENERAL AMERICAN INVESTORS CO INC |
13F
|
Company |
0.3%
|
260,261
|
$5,470,686 | — | 30 Jun 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.29%
|
253,080
|
$5,320,000 | — | 30 Jun 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.28%
|
250,000
|
$5,255,000 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
249,847
|
$5,251,774 | — | 30 Jun 2025 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
239,738
|
$5,123,201 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.26%
|
226,390
|
$4,758,718 | — | 30 Jun 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.25%
|
220,952
|
$4,644,411 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.25%
|
217,320
|
$4,568,066 | — | 30 Jun 2025 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q3 2025
As of 30 Sep 2025,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
221 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,078,963 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., Capital Research Global Investors, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, FEDERATED HERMES, INC., Point72 Asset Management, L.P., BAKER BROS. ADVISORS LP, STATE STREET CORP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
221
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
201
Q3 2025 holders
221
Holder diff
20
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.